Second look reveals potential for Columbia Labs drug - FierceBiotech

Second look reveals potential for Columbia Labs drug - FierceBiotech: "After reporting last February that progesterone gel failed to hit its primary endpoint and all secondary endpoints for preventing preterm births, Columbia Laboratories says that a second look at the late-stage data showed evidence that the drug could delay cervical shortening, which increases preterm delivery risks."